Dr Emma Davis
PhD MSc MRes
I am a Postdoctoral Researcher in infectious disease epidemiology working with Deirdre Hollingsworth and the Neglected Tropical Disease Modelling Consortium. My main disease of focus is currently lymphatic filariasis, a human nematode transmitted by mosquitoes that can cause permanent disability.
I trained as a mathematician at the University of Warwick, with a dissertation in mathematical modelling of STH, before moving to Imperial College London, where I completed a MRes in Biomedical Research focusing on infectious disease epidemiology and control of malaria. I then returned to Warwick for an MSc+PhD in mathematics of real-world systems under Deirdre Hollingsworth and Matt Keeling, with a specialism in modelling for neglected tropical diseases (NTDs).
My current projects include: assessing the predicted impact of the COVID-19 pandemic on lymphatic filariasis control and elimination programs; modelling COVID-19 contact tracing for the UK; and investigating the impact of vector control (e.g. insecticide-treated bednets) on achieving the WHO 2030 goals for lymphatic filariasis and preventing resurgence.
Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence
Davis EL. et al, (2021), Nature Communications, 12
Dynamics of SARS-CoV-2 with waning immunity in the UK population.
Crellen T. et al, (2021), Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 376
Engagement and adherence trade-offs for SARS-CoV-2 contact tracing.
Lucas TCD. et al, (2021), Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 376
SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission.
Fearon E. et al, (2021), The Lancet. Respiratory medicine, 9, 685 - 687
Modelling the impact of vector control on lymphatic filariasis programmes: current approaches and limitations.
Davis EL. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America